‘A little more hope:’ ALS patients taking anti-psychotic drug in clinical trial

New trial offers chance to treat debilitating and ultimately deadly neural disease without a cure

Cliff Barr has no illusions about how his life is going to end but he still has hope.

The 70-year-old from Okotoks, Alta., is one of 100 patients taking part in new Canada-wide clinical trial to treat ALS — a debilitating and ultimately deadly neural disease that has few treatments and no cure.

“It is a difficult and an awkward disease,” Barr said Thursday at the University of Calgary, which is running the trial.

“I found the idea of the clinical trial promising. It gives you a little more hope.”

Barr was diagnosed with amyotrophic lateral sclerosis, also known as Lou Gehrig’s disease, in October. It causes paralysis because the brain is no longer able to communicate with the body’s muscles.

Over time, as the muscles break down, an ALS patient loses the ability to walk, talk, eat, swallow and, eventually, breathe. Experts say one in 400 Canadians will die of ALS.

Even on good days, Barr said, the disease is always there.

“The disease kind of reared its head and I’m a little weaker than normal,” said Barr, who retired 10 years ago. “This morning, I couldn’t do my pants up. I couldn’t brush my hair. I needed help doing the zipper up on this sweater.”

Dr. Lawrence Korngut from the University of Calgary’s Cumming School of Medicine is running the clinical trial over the next 1 1/2 years at nine different Canadian universities.

He said an anti-psychotic drug called pimozide slowed down the disease in zebra fish, worms and mice, as well as in humans with ALS in a limited six-week trial a couple of years ago.

Korngut said the drug doesn’t address the primary cause of the disease, which destroys nerves. But he adds that it’s now believed that there’s an electrical failure that accompanies the breakdown.

“This treats that electrical failure. We’re hoping by preserving that electrical function, even if the cable keeps breaking down, that will buy people time.

“It will prolong life.”

Korngut said people shouldn’t jump to any conclusions about how well the trial will turn out and he’s only “cautiously optimistic.”

“We’ve been through this before. We know that sometimes animals behave very differently from humans and we just have to do things properly and find out these answers.”

Barr said he has been told he is likely to have between three and five years to live. The research is a double-blind study so only half the participants will receive the drug. The rest get a placebo.

“I am a fighter. You pay your money. You take your chances,” Barr said.

“It can’t make it better. It can’t repair the muscle damage … but it can slow down the progression which would in effect help me maintain the quality of life for longer than I would have.”

Korngut said it could be years before all the results are known and he grateful for those willing to volunteer.

“ALS is a disease of weakness but these are the strongest people I know. These people fight this disease so courageously.”

Bill Graveland, The Canadian Press

Like us on Facebook and follow us on Twitter.

Just Posted

Cowichan teams prepare for cup finals

United plays at R.A.P. on Saturday, 49ers play on Sunday

Brent Clancy to lead Cowichan Lake Chamber in 2018

Cowichan Lake is looking towards a positive future as chamber elects 2018 slate of officers

RCMP searching for man wanted on sexual assault charges

William Meers is known to frequent the Duncan area

VIDEO: Community garden progress is ‘interesting journey’: Cara Smith

Since the garden was forced to move to Ravine Park, its supporters have been heartened by support

VIDEO: Council assures minor baseball coaches: It’s Play Ball!

Worried coaches, wanted reassurance that field would be regulation sized for league play

Showers, flurries and hail all possible over South Coast on Thursday and Friday

Thunderstorms producing small hail could also be on the weather menu

B.C. Scientists witness first-ever documented killer whale infanticide

“It’s horrifying and fascinating at the same time.”

Charges formally laid against Nanaimo city manager

City of Nanaimo CAO Tracy Renee Samra charged with fear of injury/damage by another person

Okanagan Falls winery showing international photo project

Liquidity Wines will be sole Canadian show of National Geographic’s Photo Ark

Lawyer for one suspect in beating of man with autism says he’s not guilty

Ronjot Singh Dhami will turn himself in, lawyer said

Liberals awarded $100,000 contract to man at centre of Facebook data controversy

Christopher Wylie says his voter-profiling company collected private information from 50 million Facebook users

Facebook’s Zuckerberg admits mistakes in privacy scandal

Zuckerberg admits to privacy scandal involving a Trump-connected data-mining firm, but no apology

UPDATE: Former B.C. city councillor sentenced nine months for sexual assault

Dave Murray, convicted this past fall, hired a private investigator to intrude on the victim’s life.

Most Read